A 2018 overview of sixteen reports of cannabis-based medicines for neuropathic soreness, the majority of which analyzed a cannabinoid preparing identified as nabiximols (brand name title Sativex; a mouth spray that contains both THC and CBD that's accredited in certain countries but not in The usa), found minimal- to average-top quality proof that